These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 12910310)
1. Sensitivity of immunocompetent cells of DBA/2 and C57Bl/6 mice to cyclophosphamide. Masnaya NV; Churin AA; Borsuk OS; Sherstoboev EY Bull Exp Biol Med; 2003 Apr; 135(4):365-9. PubMed ID: 12910310 [TBL] [Abstract][Full Text] [Related]
2. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice. Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316 [TBL] [Abstract][Full Text] [Related]
3. [Sensitivity of the splenic immunocompetent cells of mice with different genotypes to the action of alkylating agents]. PevnitskiÄ LA; Telegin LIu; Ir KN Biull Eksp Biol Med; 1985 Aug; 100(8):213-5. PubMed ID: 3875371 [TBL] [Abstract][Full Text] [Related]
4. Effects of two bisdioxopiperazines on mouse B-and T-cell function. Dennert G; Hatlen LE; Tucker DF J Natl Cancer Inst; 1975 Mar; 54(3):621-9. PubMed ID: 804564 [TBL] [Abstract][Full Text] [Related]
5. [The nature of immunodeficiency induced by injections of lectins and cyclophosphamide]. Kondrat'eva TK; Mikheeva NV; Fontalin LN Biull Eksp Biol Med; 1988 Aug; 106(8):195-8. PubMed ID: 3261998 [TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide eradicates murine immunogenic tumor coding for a non-self-antigen and induces antitumor immunity. Salem ML; El-Naggar SA; Mahmoud HA; Elgharabawy RM; Bader AM Int J Immunopathol Pharmacol; 2018; 32():2058738418796591. PubMed ID: 30270681 [TBL] [Abstract][Full Text] [Related]
7. Seasonal dependency of the effects of rotational stress and cyclophosphamide in mice bearing lewis lung carcinoma. Zorzet S; Perissin L; Rapozzi V; Giraldi T Brain Behav Immun; 2002 Aug; 16(4):368-82. PubMed ID: 12096884 [TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer. Schiavoni G; Mattei F; Di Pucchio T; Santini SM; Bracci L; Belardelli F; Proietti E Blood; 2000 Mar; 95(6):2024-30. PubMed ID: 10706870 [TBL] [Abstract][Full Text] [Related]
9. [Shengqifuzheng Injection promotes the recovery of B cells in gut-associated lymphoid tissues of mice treated with cyclophosphamide]. Deng X; Huang R; Wen R; Luo X; Zhou L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1073-7. PubMed ID: 27412939 [TBL] [Abstract][Full Text] [Related]
10. Transfer of immunity by transfer of bone marrow cells: a requirement for T lymphocytes and sensitivity to cyclophosphamide. Marusić M Exp Hematol; 1978 Oct; 6(9):725-37. PubMed ID: 361429 [TBL] [Abstract][Full Text] [Related]
11. Selective action of cyclophosphamide on T and B cell activity. Sigel MM; Huggins EM; Wood DM; Ghaffar A Prog Clin Biol Res; 1984; 161():241-8. PubMed ID: 6333031 [No Abstract] [Full Text] [Related]
12. Influence of cyclophosphamide on the delayed hypersensitivity of the mouse. Kerckhaert JA; Van den Berg GJ; Willers JM Ann Immunol (Paris); 1974; 125(3):415-26. PubMed ID: 4606666 [No Abstract] [Full Text] [Related]
13. T-suppressor cells sensitive to cyclophosphamide and to its in vitro active derivative 4-hydroperoxycyclophosphamide control the mitogenic response of murine splenic B cells to dextran sulfate. A direct proof for different sensitivities of lymphocyte subsets to cyclophosphamide. Diamantstein T; Willinger E; Reiman J J Exp Med; 1979 Dec; 150(6):1571-6. PubMed ID: 159940 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of cyclophosphamide on the B and T cell compartments of adult mice. Stockman GD; Heim LR; South MA; Trentin JJ J Immunol; 1973 Jan; 110(1):277-82. PubMed ID: 4539834 [No Abstract] [Full Text] [Related]
15. Host distribution and response to antitumor alkylating agents of EMT-6 tumor cells from subcutaneous tumor implants. Holden SA; Emi Y; Kakeji Y; Northey D; Teicher BA Cancer Chemother Pharmacol; 1997; 40(1):87-93. PubMed ID: 9137536 [TBL] [Abstract][Full Text] [Related]
16. Oxymetholone modulates cell-mediated immunity in male B6C3F1 mice. Karrow NA; McCay JA; Brown R; Musgrove D; Munson AE; White KL Drug Chem Toxicol; 2000 Nov; 23(4):621-44. PubMed ID: 11071398 [TBL] [Abstract][Full Text] [Related]
17. Histological changes in spleen and lymph nodes of mice administered cyclophosphamide and levan. Siegal A; Kopel S; Leibovici J Cell Tissue Res; 1986; 245(1):183-8. PubMed ID: 3488127 [TBL] [Abstract][Full Text] [Related]
18. Reconstitution of the cellular immune response by lactoferrin in cyclophosphamide-treated mice is correlated with renewal of T cell compartment. Artym J; Zimecki M; Kruzel ML Immunobiology; 2003; 207(3):197-205. PubMed ID: 12777061 [TBL] [Abstract][Full Text] [Related]
19. Suppressive effect of mizoribine on humoral antibody production in DBA/2 mice. Okubo M; Chen XM; Kamata K; Masaki Y; Uchiyama T Transplantation; 1986 Apr; 41(4):495-8. PubMed ID: 3485844 [TBL] [Abstract][Full Text] [Related]
20. [Effect of lysozyme on the growth of murine lymphoma and antineoplastic activity of cyclophosphamide]. Shcherbakova EG; Bukhman VM; Isakova EB; Bodiagin DA; Arkhipova NA; Rastunova GA; Vorob'eva LS; Lipatov NN Antibiot Khimioter; 2002; 47(11):3-8. PubMed ID: 12698573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]